Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Medicinal Chemistry
  4. Volume 17, Issue 31
  5. Article
Volume 17, Issue 31
  • ISSN: 0929-8673
  • E-ISSN: 1875-533X

Abstract

Medicinal Inorganic Chemistry offers the high diversity of metal coordination chemistry for the development of bioactive compounds for therapeutic or diagnostic medicinal purposes. The design of novel metal-based antitumor agents occupies a privileged position in this discovery process. On the other hand, the research on metal-based radiopharmaceuticals for therapy and imaging is a subarea of high priority and development. This review describes therapeutic applications of metal compounds directed towards hypoxic tissues. Strategies in the search for new bioreductive metal-based prodrugs will be discussed. In addition, approaches for the imaging of hypoxic tissues by using metal radionuclides will be exemplified.

© Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cmc/10.2174/092986710793213797
2010-11-01
2025-06-14

  • From This Site

    /content/journals/cmc/10.2174/092986710793213797
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

/content/journals/cmc/10.2174/092986710793213797
Loading

  • Article Type:     Research Article
Keyword(s): 2-methyl-5-nitro-imidazole derivatives; activated by bioreduction; activation by bioreduction; aerobic cytotoxicity; aliphatic mustards; amineoxime-type chelators; animal metastatic foci; annihilation radiation; antecedent; anti-tumor effects; anticancer agents; anticancer chemotherapy; antitumor agents; antitumoral activity of cisplatin; aromatic N-oxides; aziridine complexes; bidentate ali-phatic nitrogen mustards; Bioreduced in Biological Media; bioreduction; bioreduction and radiotherapy; bioreductive metal-based prodrugs; bioreductive prodrugs; carboplatin; chelating bioligands; Chemo preventive; cisplatin; conventional antitumoral drugs; Cu-bis(thiosemicarbazone) complexes; diabetic retinopathy; diagnostic medicinal purposes; electrochemical behavior; hydrophilic solvents; hypoxia; hypoxia selective cytotoxins; Hypoxia selectivity; hypoxia selectivity; hypoxia-selective cytotoxins; hypoxia-selective nitroimidazoles; hypoxic solid tumors; Hypoxic Tissues; hypoxic tissues; labile high-spin Co(II) octahedral complexes; lipophilicity; magnetic resonance imaging (MRI); medicinal purposes; metal-based anticancer drugs; metal-based compounds; Metal-Radionuclide Radiopharmaceuti-cals; Misonidazole; Mitomycine C; myocardium; necrotic tissue; nitroaromatics; Nitrogen mustard ligands; nitrogen mustards; non nitro-aryl-based ra-diotracer; normoxia; novel potential hy-poxic-tissue tracers; organic chemotherapeutics; oxaliplatin; PET tracers; PnAO -1-(2-nitroimidazole); PnAO-5-0xa-6-(2-nitroimidazole); polyazamacrocyclic nitrogen mustards; potential radiotherapeutic agent; promoting metastasis and angiogenesis; Pt(IV) complexes reduction potentials; pyrrolo[3,2-f]quinoline analogues; quantitative radiolytic; quinoxalines and thiosemicarbazones metal complexes; radiodiagnosis; radiotherapy purposes; rapid acid-catalyzed dissociation; redox cycling process; slow-growing hypoxic solid tumors; solubility; sta-ble Co(II) hexaaquo species; subsequent back-oxidation; superoxide dismutase activity; superoxide forma-tion; techniques gamma scintigraphy; tetradentate polyazamacrocyclic nitrogen; Tirapazamine; Tirapazamine [62]; vanadium-prodrug complex

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test